tradmap

SURG Financials SurgePays, Inc.

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 0.9% per year over the past 5 years.
  • Operating margin has contracted, at -59.9% in the latest year.

Financial health

  • Total debt ($15M) exceeds cash ($2M); net debt is $14M.
  • Total debt has grown faster than revenue (14.3% vs 0.9% per year).
  • Operating income covered interest expense -17.0× in the latest year.
  • The company is unprofitable and has less than a year of cash runway at its current free-cash-flow burn.
Revenue & net income
-$46M $46M $137M $0 2013 2014 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-75% -16% 44% 0% 2013 2014 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-164097% -81841% 416% 0% 2013 2014 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
-$22M -$11M $781870 $0 2013 2014 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $8M $15M 2013 2014 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$21M $586453 $22M $0 2013 2014 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $57M -$36M -18.6% -59.9% 235.0% -423.6% -$21M $15M $2M
2024 $61M -$46M -23.5% -71.4% -298.6% -190.7% -$22M $4M $12M
2023 $137M $21M 26.0% 13.8% 73.0% 49.2% $5M $15M
2022 $122M -$680763 11.1% 0.5% -13.6% -2.0% $781870 $8M $7M
2021 $51M -$14M 12.1% -11.7% -381.0% -69.4% -$15M $6M
2020 $54M -$11M 4.5% -18.6% 100.0% -146.4% -$4M $8M $673995
2019 $26M -$8M 12.1% -30.2% 179.7% -84.6% -$7M $9M $346040
2018 $15M -$2M 43.8% -10.1% 77.5% -37.7% -$1M $1M $444612
2017 $3M -448.4% 90.0% $80802 $487188 $1M
2016 -$5M 136.1% -195.2% -$644877 $2M $439271
2015 -$1M 220.2% -50.9% -$234253 $747140 $69489
2014 $33299 100.7% 2.3% $794941 $37817
2014 -$55624 6.3% -2141.0% $322
2014 -$4M 415.6% -164096.9% $86
2013 $94810 -21.4% 15.7% $32126 $702047 $127219

Valuation over time

How the market has priced SURG against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 10.0 19.9 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 1.6 3.2 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is SURG growing its revenue and profit?

Over the past 5 years, SurgePays, Inc.'s revenue has grown 0.9% per year. These are computed facts, not advice.

How much debt does SURG have?

As of FY2025, SurgePays, Inc. reported $15M of total debt against $2M of cash; operating income covered interest expense -17.0×.

What is SURG's profit margin?

In FY2025, gross margin was -18.6%, operating margin -59.9%, and net margin -63.3%.

What is SURG's P/E ratio?

As of Sep '26, SurgePays, Inc. traded at a price-to-earnings ratio of about 5.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.